  Mindfulness-based interventions have proven its efficacy in treating
post-traumatic stress disorder (PTSD), but the underlying neurobiological
mechanism is unknown. To determine the neurobiological mechanism of action of
mindfulness-based stress reduction (MBSR) treating PTSD, we conducted a
randomized clinical trial (RCT) in which 98 veterans with PTSD were randomly
assigned to receive MBSR therapy (n = 47) or present-centered group therapy
(PCGT; n = 51; an active-control condition). Pre- and post-intervention
measures of PTSD symptom severity (PTSD Checklist) and brain activity measures
of electroencephalography (EEG) were assessed, including spectral power of
spontaneous neural oscillatory activities during resting and meditation
periods, time-frequency (TF) power of cognitive task-related brain responses,
and TF power of heartbeat-evoked brain responses (HEBR) that reflect cardiac
interoceptive brain responses during resting and meditation. Compared to
controls, the MBSR group had greater improvements in PTSD symptoms, spontaneous
EEG alpha (8-13 Hz) power in posterior sites, task-related frontal theta power
(4-7 Hz in 140-220 ms post-stimulus), and frontal theta HEBR (3-5 Hz and
265-328 ms post-R-peak). Latent difference score modeling found that only the
changes in the frontal theta HEBR mediated the MBSR treatment effect. Brain
source-level analysis found that the theta HEBR changes in the anterior
cingulate cortex, anterior insular cortex, and the lateral prefrontal cortex
predicted PTSD symptom improvements. These results indicated that mindfulness
meditation improves spontaneous brain activities reflecting internally oriented
relaxation and brain functions of attentional control. However, interoceptive
brain capacity enhanced by MBSR appears to be the primary cerebral mechanism
that regulates emotional disturbances and improves anxiety symptoms of PTSD.
